Home
Conditions
Stage IV Renal Cell Cancer AJCC v8

Clinical trial condition

Stage IV Renal Cell Cancer AJCC v8

Explore clinical trials studying Stage IV Renal Cell Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

49 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Stage IV Renal Cell Cancer AJCC v8 trial results

Not Yet Recruiting

Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer

NCT07716735

Conditions: Adenocarcinoma, Advanced Kidney Carcinoma, Advanced Renal Cell Carcinoma, +28 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Not Yet Recruiting

Testing the Investigational Medication Pembrolizumab After Kidney Removal for Patients With Non-Clear Cell Renal Cell Carcinoma

NCT07689240

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

NCT07516366

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Zanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

NCT07578025

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Not Yet Recruiting

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

NCT07576725

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +119 more
Locations: Uganda Cancer Institute Kampala, Uganda

View Trial Details

Not Yet Recruiting

RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

NCT07218692

Conditions: Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma, +23 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope at Irvine Lennar Irvine, California, United States

View Trial Details

Completed

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes

NCT04501913

Conditions: Adenocarcinoma, Adnexal Diseases, Carcinoma, +213 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer

NCT03473730

Conditions: Adenocarcinoma, Bladder Urothelial Carcinoma, Carcinoma, +18 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy

NCT05112627

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Completed

CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer

NCT03829111

Conditions: Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +19 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Stage IV Renal Cell Cancer AJCC v8

Stage IV Renal Cell Cancer AJCC v8 trial results

Related conditions